Recent Finacing
Recent Raise
Amberstone Biosciences develops tumor-microenvironment-activated immunotherapies for solid tumors using a high-throughput single-cell functional discovery platform to advance bispecific antibody and immunocytokine programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
